Synergy Pharmaceuticals, Inc Common Stock
SGYP
SGYP was delisted on the 7th of March, 2019.
86 hedge funds and large institutions have $118M invested in Synergy Pharmaceuticals, Inc Common Stock in 2014 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 31 increasing their positions, 28 reducing their positions, and 11 closing their positions.
55% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 11
11% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 28
8% more funds holding
Funds holding: 80 → 86 (+6)
17% less capital invested
Capital invested by funds: $142M → $118M (-$24.2M)
88% less call options, than puts
Call options by funds: $776K | Put options by funds: $6.6M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$6.69M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$1.56M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.05M |
| 4 |
Millennium Management
New York
|
+$1.05M |
| 5 |
HCM
Highbridge Capital Management
New York
|
+$1.04M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$2.2M |
| 2 |
Renaissance Technologies
New York
|
-$1.05M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$776K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$718K |
| 5 |
AGM
Alpine Global Management
New York
|
-$531K |
SGYP Hedge Fund Activity: Q2 2014 in Review
86 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Synergy Pharmaceuticals, Inc Common Stock (SGYP) for Q2 2014, worth a combined $118M — down 17% from $142M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new SGYP positions and 11 closed out — a net gain of 6 holders — while 31 added to existing stakes and 28 trimmed.
The largest buyer was State Street, adding an estimated $6.69M. The largest seller was Oxford Asset Management, exiting entirely with an estimated $2.2M sold.
- 86 institutional investors held Synergy Pharmaceuticals, Inc Common Stock (SGYP) as of Q2 2014, up from 80 in Q1 2014.
- Funds reported $118M of Synergy Pharmaceuticals, Inc Common Stock stock for Q2 2014, down 17% quarter-over-quarter.
- 17 funds opened new Synergy Pharmaceuticals, Inc Common Stock positions in Q2 2014 and 11 closed out, a net change of +6 holders.
- The largest Synergy Pharmaceuticals, Inc Common Stock buyer in Q2 2014 was State Street, an estimated $6.69M added.
- The largest Synergy Pharmaceuticals, Inc Common Stock seller in Q2 2014 was Oxford Asset Management, an estimated $2.2M sold.
Based on aggregated 13F filings for Q2 2014.